Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP

Abstract Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open Forum Infectious Diseases 2021-07, Vol.8 (7)
Hauptverfasser: Jawed, Muzamil, Khalid, Amna, Rubin, Mayer, Shafiq, Ramsha, Cemalovic, Nail
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page
container_title Open Forum Infectious Diseases
container_volume 8
creator Jawed, Muzamil
Khalid, Amna
Rubin, Mayer
Shafiq, Ramsha
Cemalovic, Nail
description Abstract Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.
doi_str_mv 10.1093/ofid/ofab343
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8294682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A776255883</galeid><oup_id>10.1093/ofid/ofab343</oup_id><sourcerecordid>A776255883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-978269c6d642ab60b478060256c7836f7fdd106146c0f9ec99d19e3fa7a881973</originalsourceid><addsrcrecordid>eNp9kUtLAzEUhYMoKtqdPyA7FRzNYyaPjVDqqyC0YNVlyGSSNjKTlHko_fdGKqIbuZB7Sb5zbuAAcILRJUaSXkXnq3TokuZ0BxwSSkQmZMF3f80HYNR1bwghjFGBuNwHB4lGnNP8ELyNzdBbOG2aIVi4WLWxKaPZ9HFtg9fwbLqYn8O7WNfxw4clnMxepjcZlvBFG-OD7n0M0Aeo4TzNNvTw1fcrOG_tu49DV2_gU6_LOi1YzI_BntN1Z0ff_Qg8390uJg_Z4-x-Ohk_ZiYnvM8kF4RJwyqWE10yVOZcIIZIwQwXlDnuqgojhnNmkJPWSFlhaanTXAuBJadH4Hrrux7KxlYm_arVtVq3vtHtRkXt1d-X4FdqGd-VIDJngiSDy63BUtdW-eBiwkyqyjbexGCdT_djzhkpCiFoElxsBaaNXdda97MMI_WVk_rKSX3nlPDTLR6H9f_kJ1S7ksM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP</title><source>Oxford Journals Open Access Collection</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Jawed, Muzamil ; Khalid, Amna ; Rubin, Mayer ; Shafiq, Ramsha ; Cemalovic, Nail</creator><creatorcontrib>Jawed, Muzamil ; Khalid, Amna ; Rubin, Mayer ; Shafiq, Ramsha ; Cemalovic, Nail</creatorcontrib><description>Abstract Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.</description><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofab343</identifier><identifier>PMID: 34307734</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Autoimmunity ; Complications and side effects ; Coronaviruses ; Novel ID Cases ; Pharmaceutical industry ; Risk factors ; RNA ; Severe acute respiratory syndrome ; Thrombocytopenia ; Vaccination ; Virus diseases</subject><ispartof>Open Forum Infectious Diseases, 2021-07, Vol.8 (7)</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2021</rights><rights>COPYRIGHT 2021 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-978269c6d642ab60b478060256c7836f7fdd106146c0f9ec99d19e3fa7a881973</citedby><cites>FETCH-LOGICAL-c427t-978269c6d642ab60b478060256c7836f7fdd106146c0f9ec99d19e3fa7a881973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294682/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294682/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1598,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Jawed, Muzamil</creatorcontrib><creatorcontrib>Khalid, Amna</creatorcontrib><creatorcontrib>Rubin, Mayer</creatorcontrib><creatorcontrib>Shafiq, Ramsha</creatorcontrib><creatorcontrib>Cemalovic, Nail</creatorcontrib><title>Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP</title><title>Open Forum Infectious Diseases</title><description>Abstract Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.</description><subject>Autoimmunity</subject><subject>Complications and side effects</subject><subject>Coronaviruses</subject><subject>Novel ID Cases</subject><subject>Pharmaceutical industry</subject><subject>Risk factors</subject><subject>RNA</subject><subject>Severe acute respiratory syndrome</subject><subject>Thrombocytopenia</subject><subject>Vaccination</subject><subject>Virus diseases</subject><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNp9kUtLAzEUhYMoKtqdPyA7FRzNYyaPjVDqqyC0YNVlyGSSNjKTlHko_fdGKqIbuZB7Sb5zbuAAcILRJUaSXkXnq3TokuZ0BxwSSkQmZMF3f80HYNR1bwghjFGBuNwHB4lGnNP8ELyNzdBbOG2aIVi4WLWxKaPZ9HFtg9fwbLqYn8O7WNfxw4clnMxepjcZlvBFG-OD7n0M0Aeo4TzNNvTw1fcrOG_tu49DV2_gU6_LOi1YzI_BntN1Z0ff_Qg8390uJg_Z4-x-Ohk_ZiYnvM8kF4RJwyqWE10yVOZcIIZIwQwXlDnuqgojhnNmkJPWSFlhaanTXAuBJadH4Hrrux7KxlYm_arVtVq3vtHtRkXt1d-X4FdqGd-VIDJngiSDy63BUtdW-eBiwkyqyjbexGCdT_djzhkpCiFoElxsBaaNXdda97MMI_WVk_rKSX3nlPDTLR6H9f_kJ1S7ksM</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Jawed, Muzamil</creator><creator>Khalid, Amna</creator><creator>Rubin, Mayer</creator><creator>Shafiq, Ramsha</creator><creator>Cemalovic, Nail</creator><general>Oxford University Press</general><scope>TOX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>5PM</scope></search><sort><creationdate>20210701</creationdate><title>Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP</title><author>Jawed, Muzamil ; Khalid, Amna ; Rubin, Mayer ; Shafiq, Ramsha ; Cemalovic, Nail</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-978269c6d642ab60b478060256c7836f7fdd106146c0f9ec99d19e3fa7a881973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Autoimmunity</topic><topic>Complications and side effects</topic><topic>Coronaviruses</topic><topic>Novel ID Cases</topic><topic>Pharmaceutical industry</topic><topic>Risk factors</topic><topic>RNA</topic><topic>Severe acute respiratory syndrome</topic><topic>Thrombocytopenia</topic><topic>Vaccination</topic><topic>Virus diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jawed, Muzamil</creatorcontrib><creatorcontrib>Khalid, Amna</creatorcontrib><creatorcontrib>Rubin, Mayer</creatorcontrib><creatorcontrib>Shafiq, Ramsha</creatorcontrib><creatorcontrib>Cemalovic, Nail</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Open Forum Infectious Diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jawed, Muzamil</au><au>Khalid, Amna</au><au>Rubin, Mayer</au><au>Shafiq, Ramsha</au><au>Cemalovic, Nail</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP</atitle><jtitle>Open Forum Infectious Diseases</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>8</volume><issue>7</issue><issn>2328-8957</issn><eissn>2328-8957</eissn><abstract>Abstract Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>34307734</pmid><doi>10.1093/ofid/ofab343</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open Forum Infectious Diseases, 2021-07, Vol.8 (7)
issn 2328-8957
2328-8957
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8294682
source Oxford Journals Open Access Collection; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Autoimmunity
Complications and side effects
Coronaviruses
Novel ID Cases
Pharmaceutical industry
Risk factors
RNA
Severe acute respiratory syndrome
Thrombocytopenia
Vaccination
Virus diseases
title Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T13%3A03%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20Immune%20Thrombocytopenia%20(ITP)%20Following%20COVID-19%20Vaccination%20in%20a%20Patient%20With%20Previously%20Stable%20ITP&rft.jtitle=Open%20Forum%20Infectious%20Diseases&rft.au=Jawed,%20Muzamil&rft.date=2021-07-01&rft.volume=8&rft.issue=7&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofab343&rft_dat=%3Cgale_pubme%3EA776255883%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34307734&rft_galeid=A776255883&rft_oup_id=10.1093/ofid/ofab343&rfr_iscdi=true